Report Questions Pfizer's Anti-Smoking Drug

Law360, New York (October 22, 2008, 12:00 AM EDT) -- Nonprofit researchers called for increased scrutiny of Pfizer Inc.’s Chantix following reports that the smoking-cessation drug had caused more serious injuries than any other drug in the first quarter.

The Institute for Safe Medication Practices released a study on Wednesday that claims that varenicline, a drug Pfizer markets under the names Chantix and Champix, reported more than 1,000 health problems and injuries, including 50 deaths, in the first quarter of 2008.

It is the second consecutive quarter that Chantix has had the most serious injuries, according...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.